Anti-Anxiety Agents: Clinical Trials

6 trials of Anti-Anxiety Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated, 1 unknown. 4 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 2, Terminated 1, Unknown 1
Phase 11Completed 1

Follow Anti-Anxiety Agents: new trials by email Literature Review of Anti-Anxiety Agents trials Research Report on Anti-Anxiety Agents

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stellate Ganglion Block Versus Oral Medication in Treatment of Palmar Hyperhidrosis
Bupivacaine + Lidocaine +dexamethasone, Tryptizole + Librax - Palmar Hyperhidrosis
Not applicableCompletedFayoum University462025-01-152026-02-06
Virtual Reality and Peripheral Intravenous Catheter Insertion to Children (R3VP)
control arm, anxiolytic and analgesic gas, Virtual reality mask - Virtual Reality, Catheterization, Peripheral Venous
Not applicableTerminatedUniversity Hospital, Clermont-Ferrand342021-12-062025-11-20
Effectiveness Study "HospiAvontuur":
HospiAvontuur, Midazolam - Children, Preoperative Anxiety
Not applicableUnknownPXL University College1642017-10-012018-11-20
Effectiveness of an Internet-based Intervention for the Treatment of Depression
ASCENSO, Antidepressants or in combination with anxiolytics, neuroleptics or mood stabilizers., Psychotherapy - Depression
Not applicableCompletedInstituto Milenio para Investigación en Depresión y Personalidad1672017-05-292021-04-08
Taking Account of Inobservable Periods in Longitudinal Drug Treatment Follow-up
Exposition to hypnotics or anxiolytics benzodiazepines, Exposition to non benzodiazepines antidepressants, hypnotics or anxiolytics, Medical consultation without prescription - Drug Exposition
CompletedUniversity Hospital, Toulouse1718612014-09-012016-09-05
Effects of Hallucinogens and Other Drugs on Mood and Performance
Hallucinogens and psychoactive substances - Healthy
Phase 1CompletedJohns Hopkins University202014-04-012019-05-16

Conditions studied

Depression (1)  ·  Fractures, Bone (1)  ·  Pain, Procedural (1)  ·  Psychological Well-Being (1)

Sponsors

Fayoum University (1)  ·  Instituto Milenio para Investigación en Depresión y Personalidad (1)  ·  Johns Hopkins University (1)  ·  PXL University College (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University Hospital, Toulouse (1)

Countries

Belgium (1)  ·  Chile (1)  ·  Egypt (1)  ·  France (1)  ·  United States (1)

Top investigators

Annemie IF Spooren, PhD (1)  ·  Atef M Khalil, professor (1)  ·  Roland R Griffiths, Ph.D. (1)

Results publications

PMID 34927594, PMID 38152462